SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-052255
Filing Date
2021-08-18
Accepted
2021-08-18 17:12:21
Documents
2
Period of Report
2021-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1593
2 EX-24 DOCUMENT attachment1.htm EX-24 3009
  Complete submission text file 0001209191-21-052255.txt   5970
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Kelly James Patrick (Reporting) CIK: 0001506314 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26770 | Film No.: 211187473